TIMEKEEPING IN GENETICALLY PROGRAMMED AGING

被引:17
作者
KLOEDEN, PE
ROSSLER, R
ROSSLER, OE
机构
[1] UNIV TUBINGEN, INST PHYS & THEORET CHEM, W-7400 TUBINGEN 1, GERMANY
[2] DEAKIN UNIV, DEPT COMP & MATH, GEELONG, VIC 3217, AUSTRALIA
关键词
GENETICALLY PROGRAMMED AGING; HAYFLICK EXPERIMENT; PINEAL CALCIFICATION; PLASMA MELATONIN FLUCTUATIONS; 2ND MESSENGER SYSTEMS; SLEEP PHASES; PHYSICOCHEMICAL CLOCK; PIERPAOLI EXPERIMENT;
D O I
10.1016/0531-5565(93)90001-T
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Genetically programmed aging, with its cellular genetic switching implied by the in vitro Hayflick limit, requires additional timing devices to coordinate the switching processes within the different cells of a highly complex life form. Evolutionary arguments have been presented elsewhere to support the need for a centralized timing mechanism as against a localized mean-field alternative. Extensive evidence is now available for the role of the pineal gland and its secreted melatonin in the aging process. The nightly melatonin peak changes with age, thus providing a potential signal to inform all of the cells in the organism of its age. Here it is hypothesized that the decoding of this ''durational signal'' at the cellular level is carried out with the aid of the sleep induced PCO2 changes in the blood. To test this hypothesis, modifications of the in vitro Hayflick experiment and of the in vivo Pierpaoli longevity experiment involving rhythmic addition of melatonin and pH manipulations are proposed.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 43 条
[1]  
ARENDT J, 1988, MELATONIN CLIN PERSP, P43
[2]   MELATONIN - A CHRONOBIOTIC WITH ANTIAGING PROPERTIES [J].
ARMSTRONG, SM ;
REDMAN, JR .
MEDICAL HYPOTHESES, 1991, 34 (04) :300-309
[3]  
ARMSTRONG SM, 1989, PINEAL RES REV, V7, P157
[4]  
ARNOLD GW, 1988, AUST WILDLIFE RES, V15, P129
[5]   MORTALITY KINETICS IN TOXICOLOGY STUDIES [J].
BOXENBAUM, H ;
MCCULLOUGH, CB ;
DICARLO, FJ .
DRUG METABOLISM REVIEWS, 1985, 16 (03) :321-362
[6]  
CARDINALI DP, 1985, PINEAL GLAND CURRENT, P273
[7]  
Changeux J., 1983, HOMME NEURONAL
[8]  
CHERNIACK NS, 1981, NEW ENGL J MED, V305, P325
[9]  
DEMENT W, 1990, HDB BIOL AGING, V3, P692
[10]  
Finch C. E., 1991, LONGEVITY SENESCENCE